Crossmark

Immune Checkpoint Inhibitors in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer

Crossref DOI link: https://doi.org/10.1007/s11864-018-0556-7

Published Online: 2018-06-21

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Puri, Sonam

Shafique, Michael

Gray, Jhanelle E.
License Information

Text and Data Mining valid from 2018-06-21
More Information

Article History

First Online: 21 June 2018

Compliance with Ethical Standards

:

: Sonam Puri declares that she has no conflict of interest. Michael Shafique has served on advisory boards for GlaxoSmithKline. Jhanelle E. Gray has received research funding through grants from Merck, AstraZeneca, Genentech, and Bristol-Myers Squibb, and has served on advisory boards for AstraZeneca.

: This article does not contain any studies with human or animal subjects performed by any of the authors.